Literature DB >> 25308604

Diagnostic and prognostic significance of CDKN2A/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30-positive lymphoproliferative disease.

A R Nicolae-Cristea1, M F Benner, W H Zoutman, R van Eijk, P M Jansen, C P Tensen, R Willemze.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25308604     DOI： 10.1111/bjd.13476

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  7 in total

1.  Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.

Authors:  Fuad Huaman Garaicoa; Alejandro Roisman; Mariana Arias; Carla Trila; Miguel Fridmanis; Alejandra Abeldaño; Silvia Vanzulli; Marina Narbaitz; Irma Slavutsky
Journal:  Tumour Biol       Date:  2016-07-29

Review 2.  The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.

Authors:  Rein Willemze; Lorenzo Cerroni; Werner Kempf; Emilio Berti; Fabio Facchetti; Steven H Swerdlow; Elaine S Jaffe
Journal:  Blood       Date:  2019-01-11       Impact factor: 22.113

Review 3.  Cutaneous T cell lymphoma.

Authors:  Reinhard Dummer; Maarten H Vermeer; Julia J Scarisbrick; Youn H Kim; Connor Stonesifer; Cornelis P Tensen; Larisa J Geskin; Pietro Quaglino; Egle Ramelyte
Journal:  Nat Rev Dis Primers       Date:  2021-08-26       Impact factor: 52.329

4.  PLCG1 Gene Mutations in Cutaneous T-Cell Lymphomas Revisited.

Authors:  Cornelis P Tensen
Journal:  J Invest Dermatol       Date:  2015-09       Impact factor: 8.551

5.  PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma.

Authors:  Fengjie Liu; Yumei Gao; Bufang Xu; Shan Xiong; Shengguo Yi; Jingru Sun; Zhuojing Chen; Xiangjun Liu; Yingyi Li; Yuchieh Lin; Yujie Wen; Yao Qin; Shuxia Yang; Hang Li; Trilokraj Tejasvi; Lam Tsoi; Ping Tu; Xianwen Ren; Yang Wang
Journal:  Blood       Date:  2022-01-27       Impact factor: 22.113

Review 6.  CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies.

Authors:  Lucia Prieto-Torres; Socorro M Rodriguez-Pinilla; Arantza Onaindia; Mariano Ara; Luis Requena; Miguel Á Piris
Journal:  Haematologica       Date:  2019-01-10       Impact factor: 9.941

7.  Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides.

Authors:  Armando N Bastidas Torres; Davy Cats; Hailiang Mei; Karoly Szuhai; Rein Willemze; Maarten H Vermeer; Cornelis P Tensen
Journal:  Genes Chromosomes Cancer       Date:  2018-10-25       Impact factor: 5.006
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.